One study aims to treat heart failure with intracoronary injection of a chimeric AAV2/AAV8 vector delivering protein phosphatase inhibitor 1 under control of the CMV promoter to block protein phosphatase 1 (NAN-101, NCT041796643). This evidence concerns the gene PPP1R1A and heart failure.